Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Teijin prepares factor Xa inhibitor series

Aug. 6, 1999

Health Canada approves Integrilin for marketing

Aug. 6, 1999

Hoechst Marion Roussel reveals new anticoagulants with advantages over heparin

Aug. 4, 1999

Genentech seeks FDA approval for tenecteplase

Aug. 3, 1999

New thrombin inhibitor approved in Italy for antithrombotic prophylaxis

July 29, 1999

Anthranilide anticoagulants developed by Schering AG researchers

July 29, 1999

Antiplatelet agents acting as IP receptor agonists developed at Fujisawa

July 23, 1999

Brain '99: lanoteplase improves microcirculation in ischemic brain

July 22, 1999

Wide series of factor Xa inhibitors specifically claimed by DuPont

July 20, 1999

New coagulation factor inhibitors under study at Merck KGaA

July 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...